A detailed history of Beacon Capital Management, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Beacon Capital Management, LLC holds 137 shares of ZTS stock, worth $24,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares
137
Previous 108 26.85%
Holding current value
$24,840
Previous $18,000 27.78%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$145.54 - $178.83 $4,220 - $5,186
29 Added 26.85%
137 $23,000
Q1 2024

May 16, 2024

BUY
$165.67 - $199.94 $7,455 - $8,997
45 Added 71.43%
108 $18,000
Q1 2023

Apr 20, 2023

SELL
$145.48 - $175.02 $1,163 - $1,400
-8 Reduced 11.27%
63 $10,000
Q4 2022

Jan 27, 2023

BUY
$131.14 - $157.47 $1,049 - $1,259
8 Added 12.7%
71 $0
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $11,427 - $14,743
63 New
63 $12,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Beacon Capital Management, LLC Portfolio

Follow Beacon Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Capital Management, LLC with notifications on news.